Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060083 · ClinicalTrials.gov registry record · Phase 2
Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day
A Phase 2 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT03060083 is a Phase 2 study that has completed, run by University of Vermont. The registered enrollment target is 74 participants.
The verdict
NCT03060083, a Phase 2 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
The FDA recently gained the authority to regulate the nicotine content of cigarettes. Prior research suggests that smokers who switch to very low nicotine content (VLNC) cigarettes experience reduced addiction to nicotine and are more likely to quit smoking. Currently, the most common method for smokers to reduce their nicotine intake is to reduce their number of cigarettes per day (CPD). No research has compared reducing smokers' nicotine intake by switching to VLNC cigarettes vs by reducing CPD with regard to decreasing dependence or quitting; thus the investigators will examine the two strategies by randomizing smokers to 1) switch to VLNC cigarettes or 2) reduce CPD. In addition, all smokers will use the nicotine patch to help them reduce their nicotine intake.
Interventions
- OTHER Very low nicotine content (VLNC) cigarettes and nicotine replacement therapy (NRT)
- OTHER Reduce cigarettes per day (CPD) with nicotine replacement therapy (NRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2017-02-08 |
| Est. Completion | 2018-01-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03060083
The ClinicalTrials.gov registry entry for NCT03060083 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Very low nicotine content (VLNC) cigarettes and nicotine replacement therapy (NRT) is the first listed.
NCT03060083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03060083 about?
NCT03060083 is a clinical study titled "Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day". The FDA recently gained the authority to regulate the nicotine content of cigarettes. Prior research suggests that smokers who switch to very low nicotine content (VLNC) cigarettes experience reduced addiction to nicotine and are more likely to quit smoking. Currently, the most common method for smo...
What is the current status of trial NCT03060083?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2017-02-08. Estimated completion is 2018-01-10.
What interventions are being tested in trial NCT03060083?
The interventions under investigation include: Very low nicotine content (VLNC) cigarettes and nicotine replacement therapy (NRT) (OTHER), Reduce cigarettes per day (CPD) with nicotine replacement therapy (NRT) (OTHER).
Who is sponsoring clinical trial NCT03060083?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.